阿那非抑制离体羊逼尿肌的收缩性

IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL
A. Dhruva, V. Hamsavardhini, Shiny Kamatham, Anushka Kataria, Aniket Kumar, M. Shanthi, J. Peedicayil
{"title":"阿那非抑制离体羊逼尿肌的收缩性","authors":"A. Dhruva, V. Hamsavardhini, Shiny Kamatham, Anushka Kataria, Aniket Kumar, M. Shanthi, J. Peedicayil","doi":"10.4103/ijabmr.IJABMR_339_18","DOIUrl":null,"url":null,"abstract":"Context: Avanafil is a smooth muscle relaxant that is clinically used to treat erectile dysfunction. It is an inhibitor of phosphodiesterase-5 (PDE5), the enzyme that catalyzes the metabolism of cyclic guanosine monophosphate (cGMP). The inhibitory effect of avanafil on isolated detrusor muscle contractility has not been studied. Aims: This study investigated the inhibitory effect of avanafil on isolated caprine (goat) detrusor muscle contractility and the possible mechanisms involved. Settings and Design: 80 mM potassium chloride (KCl)-induced contractility of the isolated goat detrusor was studied using a physiograph. Materials and Methods: Ten caprine detrusor strips were made to contract using 80 mM KCl before and after addition of three concentrations (10, 30, and 60 μM) of avanafil. Three reversal agents, ODQ, a guanylyl cyclase inhibitor; glibenclamide, an adenosine triphosphate (ATP)-sensitive potassium channel blocker; and iberiotoxin, a calcium-sensitive potassium (BKCa) channel blocker, were investigated for their ability to reverse the inhibitory effect of 30 μM avanafil on KCl-induced detrusor contractility. Statistical Analysis Used: The nonparametric statistical test, Kruskal–Wallis test, was used for the analysis of the data. Results: Avanafil caused a statistically significant inhibition of detrusor contractility at 30 and 60 μM concentrations. The inhibitory effect of 30 μM avanafil on detrusor contractility was significantly reversed by the addition of ODQ, glibenclamide, and iberiotoxin. Conclusions: Avanafil inhibits the contractility of the isolated detrusor by inhibiting PDE5, leading to raised cellular levels of cGMP. The raised levels of cGMP could have inhibited detrusor contractility by activating cGMP-dependent protein kinase, by opening ATP-sensitive potassium channels, and by opening BKCa. Avanafil could be evaluated for treating clinical conditions requiring relaxation of the detrusor like overactive bladder.","PeriodicalId":13727,"journal":{"name":"International Journal of Applied and Basic Medical Research","volume":"9 1","pages":"231 - 235"},"PeriodicalIF":0.8000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Avanafil Inhibits the Contractility of the Isolated Caprine Detrusor Muscle\",\"authors\":\"A. Dhruva, V. Hamsavardhini, Shiny Kamatham, Anushka Kataria, Aniket Kumar, M. Shanthi, J. Peedicayil\",\"doi\":\"10.4103/ijabmr.IJABMR_339_18\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Context: Avanafil is a smooth muscle relaxant that is clinically used to treat erectile dysfunction. It is an inhibitor of phosphodiesterase-5 (PDE5), the enzyme that catalyzes the metabolism of cyclic guanosine monophosphate (cGMP). The inhibitory effect of avanafil on isolated detrusor muscle contractility has not been studied. Aims: This study investigated the inhibitory effect of avanafil on isolated caprine (goat) detrusor muscle contractility and the possible mechanisms involved. Settings and Design: 80 mM potassium chloride (KCl)-induced contractility of the isolated goat detrusor was studied using a physiograph. Materials and Methods: Ten caprine detrusor strips were made to contract using 80 mM KCl before and after addition of three concentrations (10, 30, and 60 μM) of avanafil. Three reversal agents, ODQ, a guanylyl cyclase inhibitor; glibenclamide, an adenosine triphosphate (ATP)-sensitive potassium channel blocker; and iberiotoxin, a calcium-sensitive potassium (BKCa) channel blocker, were investigated for their ability to reverse the inhibitory effect of 30 μM avanafil on KCl-induced detrusor contractility. Statistical Analysis Used: The nonparametric statistical test, Kruskal–Wallis test, was used for the analysis of the data. Results: Avanafil caused a statistically significant inhibition of detrusor contractility at 30 and 60 μM concentrations. The inhibitory effect of 30 μM avanafil on detrusor contractility was significantly reversed by the addition of ODQ, glibenclamide, and iberiotoxin. Conclusions: Avanafil inhibits the contractility of the isolated detrusor by inhibiting PDE5, leading to raised cellular levels of cGMP. The raised levels of cGMP could have inhibited detrusor contractility by activating cGMP-dependent protein kinase, by opening ATP-sensitive potassium channels, and by opening BKCa. Avanafil could be evaluated for treating clinical conditions requiring relaxation of the detrusor like overactive bladder.\",\"PeriodicalId\":13727,\"journal\":{\"name\":\"International Journal of Applied and Basic Medical Research\",\"volume\":\"9 1\",\"pages\":\"231 - 235\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2019-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Applied and Basic Medical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ijabmr.IJABMR_339_18\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Applied and Basic Medical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijabmr.IJABMR_339_18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 6

摘要

背景:Avanafil是一种平滑肌松弛剂,临床上用于治疗勃起功能障碍。它是磷酸二酯酶-5(PDE5)的抑制剂,PDE5是催化环磷酸鸟苷(cGMP)代谢的酶。阿凡那非对离体逼尿肌收缩力的抑制作用尚未得到研究。目的:研究阿凡那非对山羊逼尿肌收缩的抑制作用及其可能的机制。设置和设计:使用自然图研究80mM氯化钾(KCl)诱导的山羊逼尿肌收缩性。材料和方法:在添加三种浓度(10、30和60μM)的阿凡那非之前和之后,使用80mM KCl使10条山羊逼尿肌条收缩。三种逆转剂,ODQ,一种鸟苷酸环化酶抑制剂;三磷酸腺苷(ATP)敏感性钾通道阻滞剂格列本脲;和钙敏感钾(BKCa)通道阻断剂iberiotoxin,研究了它们逆转30μM阿凡那非对KCl诱导的逼尿肌收缩力的抑制作用的能力。使用的统计分析:使用非参数统计检验Kruskal–Wallis检验对数据进行分析。结果:Avanafil在30和60μM浓度下对逼尿肌收缩力有统计学意义的抑制作用。添加ODQ、格列本脲和iberiotoxin可显著逆转30μM阿凡那非对逼尿肌收缩力的抑制作用。结论:Avanafil通过抑制PDE5抑制离体逼尿肌的收缩性,导致细胞cGMP水平升高。cGMP水平的升高可能通过激活cGMP依赖性蛋白激酶、打开ATP敏感的钾通道和打开BKCa来抑制逼尿肌收缩性。Avanafil可用于治疗需要松弛逼尿肌样膀胱过度活动的临床情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Avanafil Inhibits the Contractility of the Isolated Caprine Detrusor Muscle
Context: Avanafil is a smooth muscle relaxant that is clinically used to treat erectile dysfunction. It is an inhibitor of phosphodiesterase-5 (PDE5), the enzyme that catalyzes the metabolism of cyclic guanosine monophosphate (cGMP). The inhibitory effect of avanafil on isolated detrusor muscle contractility has not been studied. Aims: This study investigated the inhibitory effect of avanafil on isolated caprine (goat) detrusor muscle contractility and the possible mechanisms involved. Settings and Design: 80 mM potassium chloride (KCl)-induced contractility of the isolated goat detrusor was studied using a physiograph. Materials and Methods: Ten caprine detrusor strips were made to contract using 80 mM KCl before and after addition of three concentrations (10, 30, and 60 μM) of avanafil. Three reversal agents, ODQ, a guanylyl cyclase inhibitor; glibenclamide, an adenosine triphosphate (ATP)-sensitive potassium channel blocker; and iberiotoxin, a calcium-sensitive potassium (BKCa) channel blocker, were investigated for their ability to reverse the inhibitory effect of 30 μM avanafil on KCl-induced detrusor contractility. Statistical Analysis Used: The nonparametric statistical test, Kruskal–Wallis test, was used for the analysis of the data. Results: Avanafil caused a statistically significant inhibition of detrusor contractility at 30 and 60 μM concentrations. The inhibitory effect of 30 μM avanafil on detrusor contractility was significantly reversed by the addition of ODQ, glibenclamide, and iberiotoxin. Conclusions: Avanafil inhibits the contractility of the isolated detrusor by inhibiting PDE5, leading to raised cellular levels of cGMP. The raised levels of cGMP could have inhibited detrusor contractility by activating cGMP-dependent protein kinase, by opening ATP-sensitive potassium channels, and by opening BKCa. Avanafil could be evaluated for treating clinical conditions requiring relaxation of the detrusor like overactive bladder.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
46
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信